Significant Ownership of TANG CAPITAL MANAGEMENT LLC

Notable people
Kevin Tang
Signature - Title
/s/ Kevin Tang - Manager
Location
San Diego, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by TANG CAPITAL MANAGEMENT LLC.

Notify me when TANG CAPITAL MANAGEMENT LLC files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of TANG CAPITAL MANAGEMENT LLC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ITOS ITeos Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $101,100 -$38,586,756 10,000 -100% TANG CAPITAL MANAGEMENT, LLC 29 Aug 2025
CRGX Cargo Therapeutics, Inc. Common Stock, par value $0.001 per share 100% $44,700 -$13,631,846 10,000 -100% TANG CAPITAL MANAGEMENT, LLC 19 Aug 2025
ALLK Allakos Inc. Common Stock, par value $0.001 per share 100% $3,200 -$2,778,780 10,000 -100% TANG CAPITAL MANAGEMENT, LLC 15 May 2025
CMPX Compass Therapeutics, Inc. Common Stock, par value $0.0001 per share 10% $60,117,785 +$12,881,057 17,176,510 +27% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
KALV KalVista Pharmaceuticals, Inc. Common Stock, par value $0.001 per share 9.9% $63,650,358 4,941,798 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 per share 9.9% $6,208,827 8,223,612 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 9.9% $1,296,343 3,812,773 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
PLRX Pliant Therapeutics, Inc. Common Stock, par value $0.0001 per share 9.6% $9,198,699 5,859,044 TANG CAPITAL MANAGEMENT, LLC 03 Mar 2025
AUPH Aurinia Pharmaceuticals Inc. Common Shares, no par value 9.2% $176,593,980 +$31,768,000 12,229,500 +22% TANG CAPITAL MANAGEMENT, LLC 27 Feb 2026
PMVP PMV Pharmaceuticals, Inc. Common Stock, par value $0.00001 per share 8.9% $6,702,907 4,720,357 TANG CAPITAL MANAGEMENT, LLC 16 Sep 2025
GLPG Galapagos NV Ordinary shares, no par value 8.4% $192,587,107 +$22,486,521 5,559,674 +13% TANG CAPITAL MANAGEMENT, LLC 27 Oct 2025
DERM Journey Medical Corporation Common Stock, par value $0.0001 per share 8% $14,020,746 1,854,596 TANG CAPITAL MANAGEMENT, LLC 31 Mar 2025
CAPR Capricor Therapeutics, Inc. Common Stock, par value $0.001 per share 6.6% $98,136,074 3,399,900 TANG CAPITAL MANAGEMENT, LLC 16 Jan 2026
IMCR Immunocore Holdings plc American Depositary Shares, each representing one ordinary share, nominal value GBP 0.002 per share 5.2% $94,662,520 2,605,608 TANG CAPITAL MANAGEMENT, LLC 17 Oct 2025
KNSA Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares, nominal value $0.000273235 per share 5.2% $46,556,874 2,178,609 TANG CAPITAL MANAGEMENT, LLC 28 Mar 2025
CBIO Crescent Biopharma, Inc. Ordinary Shares, $0.001 par value per share 5% $8,785,000 700,000 TANG CAPITAL MANAGEMENT, LLC 02 Oct 2025
ELEV Elevation Oncology, Inc. Common Stock, par value $0.0001 per share 5% $1,183,700 -$1,112,990 3,115,000 -48% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
RVPH Reviva Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 4.8% $1,325,990 -$199,028 3,399,975 -13% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
BOLT Bolt Biotherapeutics, Inc. Common Stock, par value $0.00001 per share 3.5% $355,790 -$531,990 66,879 -60% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
OTLK Outlook Therapeutics, Inc. Common Stock, par value $0.01 per share 3.4% $3,030,000 -$808,000 1,500,000 -21% TANG CAPITAL MANAGEMENT, LLC 30 Jun 2025
TARS Tarsus Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share 2.8% $89,776,771 -$95,634,047 1,188,624 -52% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
SYRE Spyre Therapeutics, Inc. Common Stock, par value $0.0001 per share 2.4% $62,064,160 -$42,895,840 1,892,200 -41% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
NKTX Nkarta, Inc. Common Stock, par value $0.0001 per share 2.1% $2,739,523 -$10,236,562 1,480,823 -79% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
EOLS Evolus, Inc. Common Stock, par value $0.00001 per share 1.9% $7,038,160 -$21,197,145 1,245,692 -75% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 per share 0.1% $51,050 6,158 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
HELP Cybin Inc. Common Stock, no par value 0% $0 -$14,146,650 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
EPIX ESSA Pharma Inc. Common Shares, no par value per share 0% $0 -$821,300 0 -100% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
ALXO ALX Oncology Holdings Inc. Common Stock, par value $0.001 per share 0% $0 -$5,779,625 0 -100% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025
DTIL Precision BioSciences, Inc. Common Stock, par value $0.000005 per share 0% $0 -$2,767,395 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
SLRN Acelyrin, Inc. Common Stock, par value $0.00001 per share 0% $0 -$21,620,498 0 -100% TANG CAPITAL MANAGEMENT, LLC 21 May 2025
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 0% $0 -$47,582,347 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
KROS Keros Therapeutics, Inc. Common Stock, par value $0.0001 per share 0% $0 -$47,170,188 0 -100% TANG CAPITAL MANAGEMENT, LLC 31 Dec 2025
HLVX HilleVax, Inc. Common Stock, par value $0.0001 per share 0% $0 -$10,135,200 0 -100% TANG CAPITAL MANAGEMENT, LLC 17 Sep 2025
MNPR Monopar Therapeutics Inc. Common Stock, par value $0.001 per share 0% $0 0 TANG CAPITAL MANAGEMENT, LLC 31 Dec 2024

Schedules 13D/G Reported by TANG CAPITAL MANAGEMENT LLC:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.